Your browser doesn't support javascript.
loading
Monalizumab: inhibiting the novel immune checkpoint NKG2A.
van Hall, Thorbald; André, Pascale; Horowitz, Amir; Ruan, Dan Fu; Borst, Linda; Zerbib, Robert; Narni-Mancinelli, Emilie; van der Burg, Sjoerd H; Vivier, Eric.
Afiliação
  • van Hall T; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, 2333, ZA, Leiden, the Netherlands. T.van_Hall@lumc.nl.
  • André P; Innate Pharma Research Labs, Innate Pharma, Marseille, France.
  • Horowitz A; Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  • Ruan DF; Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  • Borst L; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, 2333, ZA, Leiden, the Netherlands.
  • Zerbib R; Innate Pharma Research Labs, Innate Pharma, Marseille, France.
  • Narni-Mancinelli E; Aix Marseille Université, INSERM, CNRS, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
  • van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, 2333, ZA, Leiden, the Netherlands.
  • Vivier E; Innate Pharma Research Labs, Innate Pharma, Marseille, France. Vivier@ciml.univ-mrs.fr.
J Immunother Cancer ; 7(1): 263, 2019 10 17.
Article em En | MEDLINE | ID: mdl-31623687
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Subfamília C de Receptores Semelhantes a Lectina de Células NK / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Neoplasias Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Subfamília C de Receptores Semelhantes a Lectina de Células NK / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Neoplasias Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda